Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells

Despite major advances, multiple myeloma (MM) remains an incurable malignancy. Recently we have found that disease stabilization was achieved in 64% of patients with advanced MM treated with the farnesyltransferase inhibitor R115777 (Zarnestra) in a phase 2 clinical trial. In order to enhance R11577...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Zhu, Kuichun, Gerbino, Elvira, Beaupre, Darrin M., Mackley, Paul A., Muro-Cacho, Carlos, Beam, Craig, Hamilton, Andrew D., Lichtenheld, Mathias G., Kerr, William G., Dalton, William, Alsina, Melissa, Sebti, Saïd M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The American Society of Hematology 2005
Konular:
Neoplasia
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895008/
https://ncbi.nlm.nih.gov/pubmed/15728126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2004-11-4307
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller